Prevalence of carbapenemases among Gram-negative bacteria in Tunisia: first report of KPC-2 producing Acinetobacter baumannii

J Infect Dev Ctries. 2023 Nov 30;17(11):1591-1597. doi: 10.3855/jidc.17978.

Abstract

Introduction: The rapid evolution of the antibacterial resistance problem worldwide, including the Mediterranean countries, constitutes a real threat to public health. This study aims to characterize carbapenemase encoding genes among Gram-negative bacteria collected from some Tunisian hospitals.

Methodology: Twenty-two clinical carbapenem-resistant Gram-negative bacteria were recovered, and identified by the matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) method. Antibiotic resistance was tested by disk diffusion method on Muller-Hinton Agar. The minimum inhibitory concentration (MIC) for imipenem was revealed by the E-test method. Carbapenemase encoding genes were screened by polymerase chain reaction (PCR). Genetic relatedness was performed by the pulsed field gel electrophoresis (PFGE) method.

Results: Our isolates, identified as K. pneumoniae (n = 7), P. mirabilis (n = 1), A. baumannii (n = 13), and P. aeruginosa (n = 1), presented high MIC values for imipenem. Enterobacerales were resistant to carbapenems due to OXA-48 production. Only, four K. pneumoniae harbored the blaNDM-1 gene. VIM-2 production was detected in P. aeruginosa. However, OXA-23 production was observed in A. baumannii isolates, one of which co-produced the KPC-2 enzyme that was identified for the first time in Tunisia in this species. A high genetic diversity was demonstrated by pulsed-field gel electrophoresis in K. pneumoniae and A. baumannii after XbaI and ApaI digestion respectively.

Conclusions: Our findings highlight the spread of various unrelated clones of carbapenemase-producers in some Tunisian hospitals as well as the spread of several carbapenemase types.

Keywords: Gram-negative bacteria; KPC-2; NDM-1; OXA-23; Tunisia; VIM-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii*
  • Anti-Bacterial Agents* / pharmacology
  • Bacterial Proteins / genetics
  • Carbapenems / pharmacology
  • Gram-Negative Bacteria
  • Imipenem / pharmacology
  • Microbial Sensitivity Tests
  • Prevalence
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Tunisia / epidemiology
  • beta-Lactamases / genetics

Substances

  • carbapenemase
  • Anti-Bacterial Agents
  • beta-Lactamases
  • Bacterial Proteins
  • Imipenem
  • Carbapenems